CD40LG and COVID-19: However, 42.0% (n = 168/400) of the people who participated had never experienced COVID-19-like symptoms before, and 13.1% (n = 22/168) and 33.3% (n = 56/168) of them had anti-SARS-CoV-2 IgM-positive and IgG-positive results, respectively.